These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Studies on the committed differentiation of CD34+ hematopoietic progenitor cells].
    Author: Pei X, Wang L, Xu L.
    Journal: Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):289-93. PubMed ID: 11243107.
    Abstract:
    OBJECTIVE: To elucidate the capacity of different hematopoietic growth factors (HGFs) combinations for inducing CD34+ cells to proliferate and differentiate committedly to granulocytes, erythrocytes, megakaryocytes and dendritic cells (DC). METHODS: CD34+ cells were isolated from umbilical cord blood by using a high-gradient magnetic cell sorting system (MACS), and expanded with HGFs in a liquid culture system. Colony forming cells and antigen expression were studied by colony forming assays and FACS. RESULTS: Different combinations of HGFs, including SCF, IL-3, IL-6, GM-CSF, Epo and Tpo increased BFU-E, CFU-GM, CFU-MK and CD41a+ cells by 14.97 +/- 2.89 fold, 14.46 +/- 3.19 fold, 34.67 +/- 4.62 fold and 17.29 +/- 2.34 fold, respectively. Combination of HGFs allowed generation of a large number of DCs. Cultures of CD34+ cells with the combination of FLT-3 ligand + GM-CSF + IL-4 + TNF-alpha yielded 24.28% +/- 2.14% CD1a+ cells, while the control cultures did not. CONCLUSION: It is possible to induce CD34+ cells to proliferate and differentiate committedly to different lineage of hematopoietic cells and DC.
    [Abstract] [Full Text] [Related] [New Search]